JT
JAZZ icon

Jupiter Topco’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jupiter Topco’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Buy
+25,100
New +$5.5M ﹤0.01% 972

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jupiter Topco's JAZZ Position: Q2 2026 in Review

Jupiter Topco opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 25,100 shares worth $6.05M. The stake represents ﹤0.01% of the portfolio and ranks #972 among its holdings.

602 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Jupiter Topco held 25,100 shares of Jazz Pharmaceuticals worth $6.05M as of Q2 2026.
  • Jazz Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #972 holding.
  • 602 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.